Detalhe da pesquisa
1.
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study.
Lancet Oncol
; 25(1): 117-125, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092009
2.
Bendamustine in the treatment of patients with indolent non-Hodgkin lymphoma refractory or relapse to rituximab treatment: An open-label, single-agent, multicenter study in China.
Cancer
; 129(4): 551-559, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541221
3.
Tislelizumab with gemcitabine and oxaliplatin in patients with relapsed or refractory classic Hodgkin lymphoma: a multicenter phase II trial.
Haematologica
; 108(8): 2146-2154, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700408
4.
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study.
Am J Hematol
; 98(4): 571-579, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683422
5.
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study.
Am J Hematol
; 98(11): 1742-1750, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647123
6.
Improved Artificial Potential Field Algorithm Assisted by Multisource Data for AUV Path Planning.
Sensors (Basel)
; 23(15)2023 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37571463
7.
Three-dimensional morphology measurement of underwater objects based on the photoacoustic effect.
Opt Lett
; 47(3): 641-644, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35103693
8.
The "m6A writer" METTL3 and the "m6A reader" IGF2BP2 regulate cutaneous T-cell lymphomas progression via CDKN2A.
Hematol Oncol
; 40(4): 567-576, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35446451
9.
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study.
Ann Hematol
; 99(11): 2589-2598, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32892275
10.
Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study.
Int J Cancer
; 143(3): 699-708, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29473150
11.
European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute Leukemia Receiving Single Umbilical Cord Blood Transplantation.
Biol Blood Marrow Transplant
; 23(12): 2118-2126, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807768
12.
[The curative efficacy of unrelated umbilical cord blood stem cells transplantation in intensified myeloablative conditioned patients with acute lymphoblastic leukemia].
Zhonghua Nei Ke Za Zhi
; 55(3): 191-5, 2016 Mar.
Artigo
em Chinês
| MEDLINE | ID: mdl-26926370
13.
Unrelated cord blood transplantation for central nervous system relapse in high-risk childhood acute lymphoblastic leukemia.
Ann Hematol
; 92(12): 1665-73, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23793915
14.
Real-world data for lenalidomide maintenance in responding patients of diffuse large B-cell lymphoma.
Cancer Med
; 12(9): 10553-10562, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36912128
15.
Clinical characteristics and outcomes of follicular lymphoma patients with extranodal involvement: analysis of a series of 1090 cases in China.
Clin Transl Oncol
; 25(6): 1821-1829, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808598
16.
Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study.
J Clin Oncol
; 41(16): 3032-3041, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996373
17.
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study.
Blood Adv
; 7(16): 4349-4357, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078706
18.
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.
Lancet Reg Health West Pac
; 34: 100720, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37283978
19.
(Bortezomib plus lenalidomide/thalidomide)- vs. (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials.
Ann Hematol
; 91(11): 1779-84, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22773209
20.
Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
Eur J Haematol
; 88(1): 39-45, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21933279